Avai Bio (AVAI) Long-Term Investments (2018 - 2020)

Avai Bio (AVAI) has 3 years of Long-Term Investments data on file, last reported at $55.0 in Q3 2020.

• For the quarter ending Q3 2020, Long-Term Investments changed N/A year-over-year to $55.0; the trailing twelve-month figure through Sep 2020 stood at $55.0 (changed N/A YoY), and the FY2020 full-year result was $55.0, changed 0.0% from the prior year.
• Long-Term Investments steadied at $55.0 in Q3 2020, from $55.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $63995.0 in Q3 2018 to a low of $55.0 in Q1 2019.
• A 3-year average of $11184.1 and a median of $577.5 in 2019 frame the typical range for Long-Term Investments.
• Peak annual rise in Long-Term Investments reached 0.0% in 2020, while the deepest fall reached 99.65% in 2020.
• Tracing AVAI's Long-Term Investments over 3 years: stood at $63995.0 in 2018, then plunged by 98.28% to $1100.0 in 2019, then plunged by 95.0% to $55.0 in 2020.
• Business Quant data shows AVAI's Long-Term Investments at $55.0 in Q3 2020, $55.0 in Q2 2020, and $55.0 in Q1 2020.